Key facts
| Price (PPV) | 497 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | uméclidiniumvilantérol |
| Class | Drugs for obstructive airway diseases |
| ATC code | R03AL03 |
| Manufacturer | GLAXO SMITHKLINE |
| Presentation | POUDRE POUR INHALATION EN RECIPIENT UNIDOSE BOITE DE 30 |
| Hospital price | 330 MAD |
| Data collected on | 9/8/2026 |
Indications
ANORO ELLIPTA est indiqué en traitement bronchodilatateur continu pour soulager les symptômes chez les patients adultes présentant une bronchopneumopathie chronique obstructive (BPCO). Source : base-donnees-publique.medicaments.gouv.fr - 21 octobre 2025
Find an open pharmacy
On-call pharmacies near you
About Anoro Ellipta 55 µg / 22 µg
Anoro Ellipta 55 µg / 22 µg belongs to the drugs for obstructive airway diseases therapeutic class. In Morocco, this drug is marketed by GLAXO SMITHKLINE and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Anoro Ellipta 55 µg / 22 µg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Anoro Ellipta 55 µg / 22 µg
Answers to common questions from Moroccan patients about this drug.